Spotlight: Building for the long game: What it really takes to industrialise cell & gene therapy at scale

Cost isn’t just efficiency it’s architecture: How advanced facilities change the cost curve of CGT production, from automation and digitalisation to scale, standardisation and multi-product flexibility.

Collaboration as infrastructure, not outsourcing: Lessons from structuring partnerships, funding criteria and internal alignment

What this unlocks for the ecosystem: How facilities like this shift what’s possible for developers, partners and patients and what smaller companies should take away now when planning their own manufacturing strategies.